bortezomib 
takeda
['mmsm']
how do you treat a standard risk, transplant ineligible older #myeloma patient? dr. shaji kumar shares best options of drd or rvd depending on existing co-morbidities. drd for standard risk is preferred if possible. #asco22 #mmsm 
Supporting, educating and connecting #myeloma patients and their loved ones while actively seeking a cure.